Pluronic F-127-functionalized magnetic ternary hybrid nanoparticles for co-delivery of paclitaxel and psoralen: a synergistic strategy to overcome multidrug resistance in triple-negative breast cancer
- DOI
- 10.3389/fphar.2026.1952492
- Published
- 2026-10-21
- Container
- Frontiers in Pharmacology
- Publisher
- Frontiers Media SA
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.3389/fphar.2026.1952492,
title = {Pluronic F-127-functionalized magnetic ternary hybrid nanoparticles for co-delivery of paclitaxel and psoralen: a synergistic strategy to overcome multidrug resistance in triple-negative breast cancer},
author = {Qian Liu and Fengjie Liu and Panpan Wang and Uladzislau E. Aharodnikau and Mulazim Hussain Asim and Manling Du and Qianwen Li and Mengjie Xie and Zhenjiang Yang and Hong Hu and Yu Cai},
year = {2026},
journal = {Frontiers in Pharmacology},
doi = {10.3389/fphar.2026.1952492},
url = {https://doi.org/10.3389/fphar.2026.1952492}
}RIS
TY - JOUR TI - Pluronic F-127-functionalized magnetic ternary hybrid nanoparticles for co-delivery of paclitaxel and psoralen: a synergistic strategy to overcome multidrug resistance in triple-negative breast cancer AU - Qian Liu AU - Fengjie Liu AU - Panpan Wang AU - Uladzislau E. Aharodnikau AU - Mulazim Hussain Asim AU - Manling Du AU - Qianwen Li AU - Mengjie Xie AU - Zhenjiang Yang AU - Hong Hu AU - Yu Cai PY - 2026 JO - Frontiers in Pharmacology DO - 10.3389/fphar.2026.1952492 UR - https://doi.org/10.3389/fphar.2026.1952492 ER -
APA
Liu, Q., Liu, F., Wang, P., Aharodnikau, U. E., Asim, M. H., Du, M., Li, Q., Xie, M., Yang, Z., Hu, H., & Cai, Y. (2026). Pluronic F-127-functionalized magnetic ternary hybrid nanoparticles for co-delivery of paclitaxel and psoralen: a synergistic strategy to overcome multidrug resistance in triple-negative breast cancer. Frontiers in Pharmacology. https://doi.org/10.3389/fphar.2026.1952492
Source records
- crossref · retrieved 2026-11-06T21:26:06.217Z